DRUG

BRIGHT MINDS BIOSCIENCES INC

DRUG·10919W405·US·Common Stock·Healthcare - Biotechnology-Activist

DRUG (BRIGHT MINDS BIOSCIENCES INC) is held by 57 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($93.5M), BlackRock, Inc. ($45.4M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($36.2M). Net institutional sentiment: Bullish.

57
Holders
(2 Elite)
$324.4M
Total Value
76% (59)
Consensus
45 buying - 14 selling
13F: Insider & Congress:
DRUGSmart Money Verdict
View all
Held by 57 funds
2 elite
Who's Trading
ActivistIMIan McDonald13.7%Jul 2, 2026
ActivistVPVestal Point Capital, LP5.0%May 15, 2026
ActivistJANUS HENDERSON GROUP PLCJANUS HENDERSON GROUP PLC13.1%May 15, 2026
ActivistVOVivo Opportunity Fund Holdings, L.P.5.2%May 12, 2026
ActivistCACormorant Asset Management, LP9.7%Apr 30, 2026
InsiderCLCormorant Asset Management, LPSell $9.8MApr 28, 2026
ActivistCOCommodore Capital LP0.3%Feb 17, 2026
ActivistPAPerceptive Advisors LLC4.6%Feb 17, 2026
ActivistADAdage Capital Management, L.P.5.6%Nov 13, 2025
ActivistSISio Capital Management, LLC2.7%Nov 12, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1.3M(+11.1%)$93.5M0.0%+90.07%
33
Increased
621,933(+57.8%)$45.4M0.0%+32.08%
42
Increased
495,743(+25.3%)$36.2M0.1%+45.11%
36
Increased
432,515(+60.4%)$31.6M0.2%+0.55%
50
Increased
297,158(+31.8%)$21.7M0.0%+19.24%
36
New
265,000$19.3M0.2%-2.70%
47
Increased
136,677(+898.5%)$10M0.0%-2.19%
45
Increased
132,764(+0.5%)$9.7M0.0%+94.83%
28
Increased
108,239(+40.1%)$7.9M0.0%+35.08%
36
Increased
88,716(+39.6%)$6.5M0.0%+81.62%
36
Increased
74,369(+53.2%)$5.4M0.0%+0.71%
38
New
60,482$4.4M0.0%-2.70%
37
Increased
53,706(+108.0%)$3.9M0.0%+25.78%
43
Decreased
52,832(-72.8%)$3.9M0.0%+28.96%
0
New
50,027$3.7M0.0%-2.70%
37
New
45,668$3.3M0.0%-2.70%
37
Increased
37,378(+46.2%)$2.7M0.0%+82.92%
36
Increased
19,422(+28.8%)$1.4M0.0%+19.60%
32
Increased
15,445(+294.3%)$1.1M0.0%-1.40%
41
Increased
15,318(+22.9%)$1.1M0.0%+111.57%
30

Showing 1-20 of 61

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used